➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
Baxter
McKesson
Medtronic
Johnson and Johnson

Last Updated: September 23, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR METOCLOPRAMIDE

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for Metoclopramide

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00003213 ↗ Drugs to Reduce the Side Effects of Chemotherapy Completed Swiss Group for Clinical Cancer Research Phase 3 1996-05-01 RATIONALE: Antiemetic drugs may help to reduce or prevent nausea and vomiting in patients treated with chemotherapy. It is not known whether receiving dexamethasone with granisetron is more effective than receiving dexamethasone with metoclopramide for reducing the side effects of chemotherapy. PURPOSE: Randomized phase III trial to compare the effectiveness of dexamethasone with either granisetron or metoclopramide in patients treated with chemotherapy.
NCT00008736 ↗ Electrogastrography (EGC) in Premature Infants With Feeding Intolerance Completed Children's Hospital of Philadelphia Phase 2 1969-12-31 Serial EGC measurements in premature infants attempting to correlate EGC measurements with signs of feeding intolerance and response to metoclopramide therapy.
NCT00008736 ↗ Electrogastrography (EGC) in Premature Infants With Feeding Intolerance Completed National Center for Research Resources (NCRR) Phase 2 1969-12-31 Serial EGC measurements in premature infants attempting to correlate EGC measurements with signs of feeding intolerance and response to metoclopramide therapy.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Metoclopramide

Condition Name

Condition Name for Metoclopramide
Intervention Trials
Nausea 17
Migraine 14
Postoperative Nausea and Vomiting 14
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Metoclopramide
Intervention Trials
Vomiting 43
Nausea 38
Migraine Disorders 30
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Metoclopramide

Trials by Country

Trials by Country for Metoclopramide
Location Trials
United States 205
Egypt 18
Canada 17
Australia 11
Turkey 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Metoclopramide
Location Trials
New York 25
Pennsylvania 15
Texas 13
Ohio 10
Illinois 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Metoclopramide

Clinical Trial Phase

Clinical Trial Phase for Metoclopramide
Clinical Trial Phase Trials
Phase 4 75
Phase 3 33
Phase 2/Phase 3 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Metoclopramide
Clinical Trial Phase Trials
Completed 85
Recruiting 48
Not yet recruiting 48
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Metoclopramide

Sponsor Name

Sponsor Name for Metoclopramide
Sponsor Trials
Montefiore Medical Center 13
Assiut University 10
Mansoura University 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Metoclopramide
Sponsor Trials
Other 254
Industry 31
NIH 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Moodys
Baxter
Boehringer Ingelheim
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.